pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Marketed
    vorasidenib citrate
    Voranigo (vorasidenib citrate)
    Low-Grade Glioma Les Laboratoires Servier SAS
  • Phase 2
    voretigene neparvovec
    Luxturna (voretigene neparvovec-rzyl)
    Choroideremia F. Hoffmann-La Roche Ltd
  • Marketed
    vorinostat
    Zolinza (vorinostat)
    Cutaneous T-Cell Lymphoma$MRK Merck & Co., Inc.
  • Phase 3
← prev
page 269 of 271
next →
Pain89
Neurology1
vorolanib
DURAVYU (vorolanib [INN])
Wet (Neovascular / Exudative) Macular Degeneration
$EYPT EyePoint, Inc.
  • Marketed
    vortioxetine hydrobromide
    Trintellix (vortioxetine hydrobromide)
    Major Depressive Disorder Takeda Pharmaceuticals USA Inc
  • Phase 2
    vosilasarm
    vosilasarm
    Human Epidermal Growth Factor Receptor 2 Negative Breast… Ellipses Pharma Ltd
  • Marketed
    vosoritide
    Voxzogo (vosoritide)
    Noonan Syndrome$BMRN BIOMARIN PHARMACEUTICAL INC
  • Phase 3
    votoplam
    votoplam
    Huntington Disease$NVS NOVARTIS AG
  • Phase 2
    vusolimogene oderparepvec
    vusolimogene oderparepvec
    Basal Cell Carcinoma (Basal Cell Epithelioma)$REPL Replimune Group, Inc.
  • Marketed
    vutrisiran
    Amvuttra (vutrisiran)
    Familial Amyloid Cardiomyopathy$ALNY ALNYLAM PHARMACEUTICALS, INC.
  • Marketed
    warfarin sodium
    Jantoven (warfarin sodium)
    Myocardial Infarction Upsher-Smith Laboratories LLC
  • Marketed
    wasp venom [Polistes] allergen extract
    Wasp Venom Protein Multidose
    Allergies Jubilant HollisterStier LLC
  • Marketed
    western diamondback rattlesnake [Crotalus atrox] + eastern diamondback rattlesnake [Crotalus adamanteus] + mojave rattlesnake [Crotalus scutulatus] + cottonmouth/water moccasin [Agkistrodon piscivorus] (polyvalent) immunoglobulin Fab antivenom [ovine]
    CroFab
    Poisoning BTG International Inc
  • Phase 3
    xaluritamig
    xaluritamig [INN]
    Metastatic Castration-Resistant Prostate Cancer (mCRPC)$AMGN AMGEN INC
  • Phase 2
    xelafaslatide
    xelafaslatide
    Retinal Pigment Epithelial (RPE) Detachment ONL Therapeutics Inc
  • Phase 1
    xirestomig
    xirestomig [INN]
    Non-Hodgkin Lymphoma Antengene Corp Ltd
  • Marketed
    yellow fever [strain 17 D-204] vaccine
    YF-Vax
    Yellow Fever Sanofi Pasteur Inc
  • Phase 2
    zabilugene almadenorepvec
    zabilugene almadenorepvec
    Pancreatic Ductal Adenocarcinoma$TOVX Theriva Biologics, Inc.
  • Marketed
    zafirlukast
    Zafirlukast
    Chronic Asthma Camber Pharmaceuticals Inc
  • Phase 2
    zagociguat
    zagociguat
    MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic A… Tisento Therapeutics Inc
  • Marketed
    zaleplon
    Zaleplon
    Insomnia Orchid Pharma Inc
  • Phase 2
    zalifrelimab
    zalifrelimab
    Cervical Cancer$AGEN AGENUS INC
  • Phase 1
    zaloblideg
    zaloblideg [INN]
    Diffuse Large B-Cell Lymphoma$ARVN ARVINAS, INC.
  • Phase 3
    zaloganan
    zaloganan [INN]
    Prosthetic Joint infections Peptilogics Inc
  • Phase 1
    zalsupindole
    zalsupindole [INN]
    Major Depressive Disorder Delix Therapeutics Inc
  • Phase 2
    zaltenibart
    zaltenibart
    Paroxysmal Nocturnal Hemoglobinuria Novo Nordisk AS
  • Phase 3
    zalunfiban acetate
    zalunfiban acetate
    Myocardial Infarction CeleCor Therapeutics Inc
  • Phase 2
    zampilimab
    zampilimab [INN]
    Idiopathic Pulmonary Fibrosis Chiesi Farmaceutici SpA
  • Preclinical
    zanamivir
    Relenza (zanamivir)
    Influenzavirus A Infections Therapeutic Systems Research Laboratories Inc
  • pre_registration
    zanidatamab
    Ziihera (zanidatamab-hrii)
    Adenocarcinoma Of The Gastroesophageal Junction$JAZZ Jazz Pharmaceuticals plc